With BIO-Europe Fall 2024 coming to an end, we’re energized by the insights, partnerships, and connections we made throughout the event. Our CEO Edita Griniute-Mistiniene represented Profarma among global leaders in biotech, and we were honored by a visit from His Excellency Ambassador Linas Linkevičius and Commercial Attaché Darius Budrys from the Embassy of the Republic of Lithuania in Sweden. Key takeaways from the event: 🔬 Networking Breakthroughs: The event felt like a lively molecular reaction, where partnerships were formed at every interaction. The biotech sector continues to be a hub for collaboration, innovation, and growth—showcasing the power of strategic "bonding" in science. ⚙️ Cutting-Edge Trends: The event highlighted the growing role of AI, digitalized quality management, and other advancements in our industry. Profarma is committed to integrating these technologies to provide faster, more precise testing solutions for our clients. 💸 Investment Focus: Venture capital interest in biotech is higher than ever, with investors actively searching for the next transformative startup. It's inspiring to see such support fueling breakthroughs that could reshape patient care. 🌱 Sustainability in Science: The push for greener, more sustainable practices is gaining momentum in biotech. As an EU GMP and MIA-certified site, we’re committed to supporting these values in our work. 🎨 Art & Science Intersection: Scientists are finding creative ways to bring science to life by transforming microscopic cell images into art, blending beauty with precision. This intersection reminds us that innovation thrives when science meets creativity. A special thanks to Innovation Agency Lithuania | Global for organizing the Lithuanian delegation. We look forward to building on the insights and connections made at BIO-Europe Fall. If you’re seeking a reliable partner in batch release testing, let’s connect! #BIOEurope2024 #BatchReleaseTesting #LifeSciences #Pharmaceuticals
Profarma
Pharmaceutical Manufacturing
Vilnius, Vilnius 6,969 followers
European testing laboratory holding MIA license and GMP certificate
About us
European testing laboratory holding MIA license as well as GMP certificate and serving the pharmaceutical industry with EU Batch Release Testing, QP Batch Release, and Product Development. Profarma‘s expertise includes small molecules, peptides, and biologics, including active pharmaceutical ingredients (API), intermediate stages, and final drug products.
- Website
-
http://www.profarmabio.com
External link for Profarma
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Vilnius, Vilnius
- Type
- Privately Held
- Founded
- 2007
- Specialties
- Biotechnology/Biopharmaceuticals, Contract research, GMP batch release testing, Batch release, Biosimilars, Analytical method transfer, Analytical methods development, qualification, validation, Stability studies, Testing of intermediate products, drug substances and drug products, (Bio)analytical testing of investigational medicinal product, Impurity profiling, Comparability studies, Reference standard preparation/qualification, and Generic drug products
Products
Locations
-
Primary
V. A. Graičiūno g. 6
Vilnius, Vilnius LT-02241, LT
Employees at Profarma
-
Edita Griniute-Mistiniene
CEO at Profarma
-
Aleksej Persijanov
Global KAM @ Profarma, MBA
-
Mindaugas Katkus
Compliance, GMP, auditing, Qualified Person
-
Aistė Mačiulytė - Kavaliauskienė
Head of Business Development department at MIA license and EU GMP certificate holding Laboratory performing EU GMP batch release testing, QP batch…
Updates
-
Today marks our first day at #BIOEurope, and we are looking forward to connecting with fellow innovators, industry experts, and partners from across the global life sciences community. Profarma is an EU GMP and MIA-certified laboratory that performs batch release testing and QP batch certification for imported pharmaceutical products. If you're attending, stop by and say hello! Our booth number is 164. #Profarma #BIOEurope #LifeSciences #Innovation #Networking #Healthcare
-
Warm Diwali Wishes from all of us at Profarma! To our partners, customers, and everyone celebrating the Festival of Lights—congratulations on this special occasion! May Diwali bring you and your loved ones joy, prosperity, and new beginnings. We deeply appreciate the vibrant connections we share with each of you and wish you a bright and meaningful celebration. Happy Diwali! #Diwali2024 #FestivalOfLights #Profarma
-
We’re excited to announce that Profarma will be attending BIO-Europe Fall this November 4-6, 2024, in Stockholm, Sweden! Profarma is an EU GMP-certified and MIA license-holding Europe-based laboratory offering batch release testing, QP batch certification, and other QC analytical services. 🔗 Let’s meet! If you’re attending BIO-Europe Fall, we’d love to explore potential collaborations and opportunities with you. Book a meeting with us in advance to secure your spot! 📅 Dates: November 4-6, 2024 📍 Location: Stockholm, Sweden Schedule a meeting with us through the BIO-Europe partnering platform or send us a message directly. We look forward to seeing you there! #BIOEurope #Pharma #Biotechnology #LifeSciences #Networking #Partnering #Profarma #BatchRelease #QPRelease #QCTesting
-
There are only a few days left until CPHI Worldwide 2024! Our leadership team, including Dr. Edita Griniute-Mistiniene (CEO), Aistė Mačiulytė - Kavaliauskienė (Head of Business Development), and Aleksej Persijanov (Key Account Manager), will be there to discuss how Profarma’s innovative solutions can support your business with EU batch release testing and QP certification services. 📩 [email protected] 🖥️ www.profarmabio.com We look forward to meeting you in Milan! #CPHIWorldwide2024 #MeetOurTeam #ScheduleAMeeting #Profarma #PharmaLeaders #BusinessPartnerships #InnovationInPharma #BatchRelease
-
⏳ Only a couple of weeks left until CPHI Milan 2024! If you haven’t done so already, we invite you to schedule a meeting with our team to discuss your existing projects or explore new business opportunities. Profarma's team can help you with batch release testing, quality control analysis, and QP batch certification of your imported products. We’re excited to connect and collaborate—see you in Milan. ✉ [email protected] 🖥 www.profarmabio.com #CPHI2024 #PharmaNetworking #Profarma #BusinessOpportunities
-
📢 Reminder: Our CEO, Dr. Edita Griniute-Mistiniene, will be speaking at the Women in Biotech event hosted by LithuaniaBIO. Join us as we celebrate and support the incredible women leading the biotech industry! 📅 Date: 27th of September, 2024 📍 Location: Tech Park at Sapiegas Palace Park, Vilnius #WomenInBiotech #LithuaniaBIO #Leadership #Biotech #WomenInSTEM
📣 Introducing our next speaker for the Women in Biotech event – Dr. Edita Griniute-Mistiniene!👏 Dr. Edita Griniutė- Mištinienė is founder and CEO of Profarma, pharmaceutical company providing Quality Control testing services as well as R&D. Edita has experience in biopharma industry for more than 20 years, at different R&D and management positions. From 2009 to 2014 she held positions of R&D and Biosimilars Director, Chief Scientific Officer and Member of Board of Directors at 3P Biopharmaceuticals (Spain), where she developed infrastructure for research and development unit, managed innovative and biosimilars R&D projects at different phases from proof-of-concept stage to clinical trials. In parallel she was one of co-founders of Profarma and provided contribution to its R&D activities, including now patented ProMER technology development. Before that, she was Head of R&D at TEVA Pharmaceuticals/Sicor for 10 years, where she led a number of innovative and biosimilar R&D projects according to EMA and FDA requirements Education: Biochemistry master’s degree in Vilnius university, PhD studies in Institute of Biotechnology, Vilnius (2004). ✅ Register and join us at the event, which will be held at Tech park in Sapiegas Palace Park, Vilnius, Lithuania on the 27th of September, 2024! 👉 More information about the event and registration: https://winb.lt/ Caszyme I VUGENE I Profarma I Pedersen & Partners I Ateities biomedicinos fondas, Labdaros ir paramos fondas I EXOLITUS I LAIMA I VDU Žemės ūkio akademija / VMU Agriculture Academy I Lietuvos inovacijų centras / Lithuanian Innovation Centre (LIC) I AAA Law #LifeScience #WomeninBiotech #Lithuania #Biotech
-
We are excited to announce that Profarma's CEO, Dr. Edita Griniutė-Mištinienė, will be speaking at the Women in Biotech event organized by #LithuanianBIO! 🎤 Join us as Edita shares her insights on creating a business in the life sciences field, highlighting the critical role of women in driving innovation in the biotech industry. Don’t miss this opportunity to gain valuable perspectives from a leader in the field! More information about the event: www.winb.lt 📅 27th September, 2024 #WomenInBiotech #Leadership #Innovation #Profarma #BiotechIndustry
-
🩺 On World Patient Safety Day, we recognize the EU's commitment to safeguarding patients from the risks of falsified medicines The EU's stringent regulations and standards are designed to ensure that every medication reaching patients is safe, effective, and meets the highest quality specifications. At Profarma, we are proud to play a vital role in this mission. As a certified EU GMP laboratory, we provide essential services like batch release testing, analytical method validation, and quality assurance to ensure that all medicines meet the exact specifications they were approved for. Together, we can continue to uphold the highest standards of patient safety and build a healthier future for all. #WorldPatientSafetyDay #PatientSafety #Profarma #QualityControl #EUPharma
-
Profarma's team is looking forward to meeting you at CPHI 2024! 🌟 With just 3 weeks to go until the event, now is the perfect time to schedule a meeting with us to discuss your batch-release testing needs. Profarma is a European laboratory holding an EU GMP certificate and MIA license, offering a comprehensive range of services including batch release testing, analytical methods development and validation, QP Certification, and product development. Let’s connect and create new opportunities together! 📩 [email protected] #CPHI2024 #PharmaNetworking #Profarma #QualityControl #BatchRelease"